STUDI KASUS BENIGN PROSTATIC HYPERPLASIA (BPH)
نویسندگان
چکیده
Benign Prostatic Hyperplasia (BPH) merupakan keadaan kondisi terjadinya penyumbatan yang terlihat pada pembesaran prostat jinak dengan tampilan histologis adenoma menyebabkan obstruksi bervariasi atau tanpa gejala. Kejadian komplikasi biasa ditimbulkan oleh BPH adalah sistitis dan anemia. Pembesaran jaringan tinggi akan penekanan uretra pars prostatika lumen mengakibatkan obstruksi. Tujuan: untuk mengulas laporan kasus pasien laki-laki berusia 76 tahun diagnose disertai Metode: artikel ini berdasarkan (case report) di RSUD dr. Soediran Mangun Sumarso, Wonogiri. Hasil: Pasien sudah mendapatkan terapi Harnal 1 x 400mcg, paracetamol 3 500 mg urinter 2 400 penyakit diderita pasien, pengobatan tersebut kurang tepat sehingga direkomendasikan penyesuaian menjadi 5-alpha reductase inhibitors (Alfuzosin 10 PO dutasteride 0,5 PO), kemudian pemberian monoterapi dapat diberikan obat Tadalafil 5 mg/hari memiliki IMT rendah gejala LUTS. Pengobatan seftriakson IV 1-2 gram/ 12-24 jam, Urinter mg/ hari, Paracetamol 325-600 4-6 jam jika perlu. Untuk anemia asam folat 500-1000 mcg multivitamin. Kesimpulan: sesuai dialami.
منابع مشابه
Benign Prostatic Hyperplasia (bph)
Comprehensive studies show that the holmium laser is ideal for treating BPH. Holmium laser treatments have been the most rigorously investigated BPH techniques. Over 90 articles have been published from 8 randomized clinical trials and over 30 case studies and comparative series. The American, European, British and Australasian urology associations recommend holmium laser for BPH treatment. Hol...
متن کاملSurgical Options for Benign Prostatic Hyperplasia (BPH)
In 1788 John Hunter first described the pathology of prostatic hyperplasia and its effects on the upper urinary tract. It took a century for the first suprapubic prostatectomy to be carried out in 1887 by AF McGill in Leeds (though Americans tend to claim credit to Fuller in New York in 1894.) The procedure was subsequently p o p u l a r i s e d b y S i r Pe t e r F r e ye r . R e t r o p u b i...
متن کاملTherapeutic Class Overview Benign Prostatic Hyperplasia (BPH) Treatments
Therapeutic Class Overview/Summary: The agents approved for the treatment of signs and symptoms of benign prostatic hyperplasia (BPH) will be the focus of this review. The α-adrenergic blockers including, alfuzosin, doxazosin, silodosin, tamsulosin, and terazosin, reduce smooth-muscle tone in the prostate and bladder neck decreasing lower urinary tract symptoms (LUTS) secondary to BPH. Alfuzo...
متن کاملIs staging of benign prostatic hyperplasia (BPH) feasible?
With better understanding of the natural history of benign prostatic hyperplasia (BPH), the treatment can be tailored to the severity of the disease. The aims of this study were to determine the feasibility of staging BPH according to its severity and choose the optimal therapeutic tool for each category, and for comparing results of various modalities of treatment. Two hundred and twenty-five ...
متن کاملBenign prostatic hyperplasia (BPH) management in the primary care setting.
Benign prostate hyperplasia (BPH) occurs in up to 50% of men by age 50, and the incidence increases with age. This common clinical problem is diagnosed by history, including the International Prostate Symptom Score (IPSS) questionnaire, and physical examination by digital rectal examination (DRE). Initial management for BPH includes lifestyle modification, and smooth muscle relaxant alpha blo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Jurnal Kedokteran
سال: 2022
ISSN: ['2527-7154', '2301-5977']
DOI: https://doi.org/10.29303/jku.v11i2.705